Galderma to buy US firm ZO Skin Health for $1.5 billion

2

ZURICH, Oct 14 (Reuters) – Swiss skincare firm Galderma said on Wednesday it had agreed to acquire US-based company ZO Skin Health for an enterprise value of $1.5 billion, confirming a report

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)